Stem Cells Spin S.A. (WSE:SCS)

Market Cap	21.70M +50.0%
Revenue (ttm)	65.18K +12.5%
Net Income	-551.71K
EPS	-0.01
Shares Out	41.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	383
Open	0.5350
Previous Close	0.5300
Day's Range	0.5250 - 0.5350
52-Week Range	0.2800 - 0.5400
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wrocław, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2009
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SCS

Financial Performance

In 2025, Stem Cells Spin's revenue was 65,736, an increase of 21.11% compared to the previous year's 54,280. Losses were -525,624, 1.03% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 26, 2026

Data Sources Report a data error